Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Selami Demirci(National Institutes of Health), Naoya Uchida(National Heart Lung and Blood Institute), Khaled Essawi(National Institutes of Health), Alexis Leonard(St. Jude Children's Research Hospital), Juan J. Haro‐Mora(National Institutes of Health), Claire Drysdale(National Institute of Diabetes and Digestive and Kidney Diseases), Raul Vizcardo(National Cancer Institute), Daniela Malide, Naritaka Tamaoki(Gifu University), John F. Tisdale(National Heart Lung and Blood Institute), Nicholas P. Restifo(Lyell Immunopharma (United States)), Keyvan Keyvanfar(National Institutes of Health)
Cited by 42
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
|Nature Clinical Practice Oncology|2006|348
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329